Lamivudine in the treatment of hepatitis B virus-related polyarteritis nodosa.
Auguet
Teresa
T
Department of Internal Medicine, Joan XXIII University Hospital, C/Dr. Mallafré Guasch 4, 43007 Tarragona, Spain. tauguet.hj23.ics@gencat.net
Barragan
Patricia
P
Ramírez
Rafael
R
Quer
Joan Carles
JC
Sirvent
Joan Josep
JJ
Richart
Cristóbal
C
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000188:drug therapy* / Q000209:etiology*
D019380:Anti-HIV Agents; D006513:Hepatitis B e Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine; D003520:Cyclophosphamide; D008775:Methylprednisolone